Last reviewed · How we verify
NCT06145945
Effect of Intraperitoneal Ropivacaine on Visceral Pain After Laparoscopic Gastrectomy
NA trial testing 0.5% Ropivacaine in Laparoscopic Gastrectomy in 72 participants. Status unknown.
3 March 2024
Quick facts
| Lead sponsor | SanQing Jin |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 72 |
| Start date | 25 November 2023 |
| Primary completion | 3 March 2024 |
| Estimated completion | 7 July 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- 0.5% Ropivacaine — full drug profile →
- Saline
Conditions studied
- Laparoscopic Gastrectomy — all drugs for Laparoscopic Gastrectomy →
- Ropivacaine — all drugs for Ropivacaine →
Sponsor
SanQing Jin — full company profile →
Who can join
Adults 18 to 65, any sex, with Laparoscopic Gastrectomy or Ropivacaine. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Visceral pain is obvious and lasts for a long time in patients after laparoscopic gastrectomy.Relieving the visceral pain is of great significance for patients' postoperative emotional experience, functional recovery and reducing the formation of long-term chronic pain. However, there is no clear clinical consensus on relieving visceral pain by now, so effective clinical methods to relieve visceral pain need to be explored urgently. Intraperitoneal spraying local anesthetics is a simple and inexpensive method, which has been proved to be safe and effective in randomized controlled trials and Meta-analysis of various types of surgery.However, its effect in clinical research is still controversial and many studies lack evaluation of postoperative recovery quality, so it has not been widely used in clinical practice. This study aims to explore the effect of intraperitoneal spraying ropivacaine (long-acting amide local anesthetic) on visceral pain after laparoscopic gastrectomy, and to systematically evaluate its effect on the recovery of gastrointestinal function and the inflammatory factors (IL-6, TNF-α) in abdominal drainage fluid.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06145945
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of 0.5% Ropivacaine
Trials testing the same drug.
- NCT07079436 — EIT Evaluation of Pulmonary Ventilation With Different Ropivacaine Concentrations in Intercostal Nerve Blockade · NA · not yet recruiting
- NCT03069183 — Ultrasound-guided Suprainguinal Fascia Iliaca Compartment Block for Analgesia After Total Hip Arthroplasty · Phase 2, PHASE3 · completed
Other recruiting trials for Laparoscopic Gastrectomy
Currently open trials in the same condition.
- NCT07029269 — Feasibility of Enhanced Recovery After Surgery Without Prophylactic Abdominal Drainage Tubes After Laparoscopic Distal G · Phase 3 · recruiting
- NCT06489288 — ERAS in Totally Laparoscopic Total Gastrectomy for Gastric Cancer · NA · active not recruiting
Other SanQing Jin trials
Trials by the same sponsor.
- NCT06685198 — Observation on Administration of Propofol at Different Titration Endpoints · NA · not yet recruiting
- NCT04595591 — Observation of Propofol Titration at Different Speeds · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06145945 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by SanQing Jin
- Last refreshed: 28 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06145945.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing